Infant formula hard copy record-keeping should be kept to a minimum, USF&P maintains.
This article was originally published in The Tan Sheet
Executive Summary
INFANT FORMULA HARD COPY RECORD-KEEPING SHOULD BE MINIMIZED, USF&P SAYS in Dec. 17 comments to FDA on the agency's proposed revision to infant formula current Good Manufacturing Practices regulations. U.S. Foods & Pharmaceuticals, a formulator, private label manufacturer and marketer based in Madison, Wisc., says with regard to record-keeping that "hard copy recording should be reduced to a minimum and attempts made to ensure that all key process results are obtained electronically."